BioClinica, Kinapse Partner on RBM Implementation

BioClinica, Inc. has partnered with Kinapse to accelerate Risk-Based Monitoring (RBM) implementation on global clinical trials using its Compass Intelligent Monitoring solution.
 
Kinapse provides strategy and operations consultancy and capability-building programs, including RBM, to life sciences companies, and works to ease the change management process as organizations transition to RBM.
 
“Implementing a comprehensive RBM solution can make a real difference in clinical research,” BioClinica chief executive officer John Hubbard said. “We’re excited about this collaboration as it helps move the industry forward with intelligent monitoring by bringing together our technology and subject matter expertise with Kinapse’s broad implementation experience.”   
 
“In evaluating RBM-enabling technologies, we found BioClinica’s Compass provides one of the most comprehensive solutions,” said Stuart Donald, vice president of advisory services of Kinapse. “Compass is uniquely designed for RBM and has a rich tool set to solve risk and quality issues, making it the right technology in this new era of monitoring.”